Allergic Asthma clinical trials

Explore recruiting allergic asthma clinical trials.

Recruiting allergic asthma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allergic Asthma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of briquilimab in participants with allergic asthma.

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A clinical study investigating OM-85-IN safety and tolerability in healthy volunteers and mild allergic asthma patients

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

SHORTEN - Impact of omalizumab withdrawal after a 3 year duration treatment in well controlled severe allergic asthma : a multicentric randomized controlled trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Therapheutic optimization of omalizumab in allergic severe asthma patients by dose and frequency of administration adjustment

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: PREDICTUMAB, an open-label, controlled, randomized multinational pragmatic trial.

Belgium, France

Therapeutic use (Phase IV) EU CTIS Study details

A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children with Severe Uncontrolled Asthma (HORIZON)

Spain, Poland, Hungary, France, Netherlands, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Allergic Asthma trials by city

Allergic Asthma in Toronto Allergic Asthma in Vancouver Allergic Asthma in Montreal Allergic Asthma in Calgary Allergic Asthma in Edmonton Allergic Asthma in Ottawa Allergic Asthma in Winnipeg Allergic Asthma in Quebec City Allergic Asthma in Hamilton Allergic Asthma in Kitchener Allergic Asthma in London Allergic Asthma in Halifax Allergic Asthma in New York Allergic Asthma in Los Angeles Allergic Asthma in Chicago Allergic Asthma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease